Company / Current Liabilities per Share
Moderna Current Liabilities per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$5.15
FY2025
5-year range
$5.15 / $22.88
FY2021-FY2025
Trend
-10.9%
vs FY2024
Sector context
#38 of 210
Health Care
What the data says
Moderna's current liabilities per share of $5.15 is higher than 82% of companies in the Health Care sector (FY2025). Current Liabilities per Share has declined for 4 consecutive years, from $22.88 in FY2021 to $5.15 in FY2025.
Based on SEC 10-K filings.
5.15 in FY2025 with a 5-year CAGR of -17.0%. Top quartile in the Health Care sector.
Improved from $7.83 to $5.15 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -25.0%
- 5-Year CAGR
- -17.0%
- 10-Year CAGR
- -
Sector benchmark
-78.4% below sector average
Key checks
Key Insights
- Moderna's current liabilities per share has declined for 4 consecutive years.
- In FY2025, current liabilities per share decreased 10.9% year-over-year.
- Ranks #38 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.15 | -10.9% |
| FY2024 | $5.77 | -26.3% |
| FY2023 | $7.83 | -35.9% |
| FY2022 | $12.22 | -46.6% |
| FY2021 | $22.88 | +75.4% |
| FY2020 | $13.04 | +2896.2% |
| FY2019 | $0.44 | -87.3% |
| FY2018 | $3.42 | +15.1% |
| FY2017 | $2.97 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026